|
THE KIDNEY.COM
|
|
IgA NEPHROPATHYIgA nephropathy is the commonest primary glomerular disease. It is seen in about 10 percent of all renal biopsies performed for primary glomerular disease in North America, 20% in Europe, and as high as 30 to 40% in the Asian Pacific area. This may reflect regional differences in the indications for renal biopsy rather than a true difference in geographic incidence. Genetic influence as well as environmental factors may also contribute. It is most common in the second and third decade, However all ages may be affected. Males are more commonly affected (2:1). Can be viewed as a monosymptomatic form of Henoch Schonlein purpura CLINICAL PICTURE:Microscopic or macroscopic hematuria is the commonest manifestation. May follow quickly upon some nonspecific virus-like syndrome or intercurrent infection (e.g. synpharyngitic nephritis) It may be precipitated by upper respiratory tract infection. Proteinuria (usually less than 1 gm per 24 hour). Blood pressure is usually normal. Dysuria may be a prominent complaint Progressive renal failure may occur. Renal function is usually normal. Slowly progressive fall in GFR usually occurs Renal biopsies are of value in estimating prognosis in individual patients. The disease recurs in 50% of transplanted kidney but is an unusual cause for graft loss. Pathogenesis:Uncertain Abnormality of IgA regulation may be present. Disease associated with IgA nephropathySkin DiseasesDermatitis herpetiformis Psoriasis Intestinal DiseasesCrohn’s disease Celiac disease Connective Tissue diseaseSeronegative arthropathy Rheumatoid arthritis Ankylosing spondylitis Reiter’s syndrome Sicca syndrome Episclerttis Neoplasia IgA monoclonal GammopathyMucin secreting carcinomaCarcinoma of lung , larynx, pharynx, pancreas Mycosis fungoides Sezary syndrome HematologicalMixed cryoglobulinemia Immune thrombocytopenia Polycythemia MiscellaneousHIV infection Toxoplasmosis Leprosy Alcoholic liver disease Portal systemic shunts Familial immunothrombocytopenia Pulmonary hemosiderosis Various pulmonary diseases Buerger’s disease Laboratory findingsUrinalysisMicroscopic or macroscopic hematuria RBCs are dysmorphic Protein excretion less than one gm in 60% of the cases. Nephrotic range proteinuria may occur in 10% Plasma IgASerum IgA levels is increased in about 50% of cases. Polymeric IgA is increased Elevated plasma IgA level is seen in up to o one half of cases. Circulating IgA containing immune complexes that roughly parallel the activity of the disease may be seen. Oral antigens that lead to activation of intestinal IgA production may be important in certain patients. After deposition in the kidney the membrane attack complex may mediate the damage. Complement levelsComplement levels are usually normal Skin biopsyBiopsies from the volar surface of the forearm reveal dermal capillary deposits of IgA, C3, properdin, and fibrin but not C1q, C4, or IgA secretory piece in 20 to 50% of cases. This pattern is similar to that found in kidney biopsies. Kidney biopsyLight MicroscopyThe most frequent abnormality is mesangial enlargement and hypercellularity. Other pictures seen include, circumscribed foci of epithelial proliferation, segmental areas of capillary collapse and hyalinosis, global sclerosis of some scattered glomeruli, interstitial changes, arteriolar hyalinosis. Virtually all of biopsies performed during episodes of gross hematuria have disclosed crescents. This lesion may be associated with a better prognosis as opposed to a chronic sclerosing lesion. It is the presence of segmental sclerosis , often with hyalinosis, which might allow for confusion of IgA nephropathy with focal and segmental glomerulosclerosis if only light microscopy is used in studying renal biopsies. Electron MicroscopyFinely granular to homogenous electron dense deposits are identified in the mesangium of all lobules of all glomeruli. in advanced lesions distortion, layering and splitting of the basement membranes may be noted. There may also be lysis of basement membrane Prominent mesangial deposition of IgA is seen in only two other disorders: henoch-Schonlein purpura, which is histologically indistinguishable from IgA nephropathy and lupus nephritis in which IgG is the primary immunoglobulin that is deposited. ImmunofluorescenceIgA is the predominant or sole immunoglobulin that is found. Some patients may have IgG deposits as well. IgM, may also be seen with the same frequency as IgG. C3 may be seen C1q and C4 are almost never found. This suggests prominent involvement of the alternative pathway of complement activation. PrognosisMost patients continue to have episodes of gross and or microscopic hematuria Occasionally long symptom free intervals may occur Spontaneous complete remissions occur in less than 4% of patients In long term studies 20 to 30% developed progressive renal insufficiency 20 years or more after initial discovery of disease It can be estimated that 1 to 2% of patients will enter end stage renal failure each year from time of diagnosis Rapid progression may occur in some patients Clinical features indicating a poor prognosis includeClinicalMale sex Late age onset Decreased GFR at diagnosis Persistent nephrotic range proteinuria and moderate hypertension Peripheral capillary IgA Persistent microscopic hematuria combined with proteinuria Renal biopsy findings ofDiffuse proliferative glomerular lesions especially if accompanied by segmental or diffuse crescents Focal and segmental glomerular sclerosis Tubule atrophy Arteriolar sclerosis Interstitial fibrosis C3 deposits may confer a worse prognosis Effect of pregnancyUnexpected deterioration of renal function in a small number of patients Pregnancy was successful and safe in patients without hypertension and with a serum creatinine less than 2.3 mg/dl Hypertension developed in one quarter of patients The presence of HLA Bw35 or DR 4 conferred a worse prognosis Treatmentno therapeutic intervention were found to be consistently successful Control of blood pressure CorticosteroidsMay reduce severity of hematuria but does not influence long term course of disease May helpful in the uncommon patients with nephrotic syndrome and mild glomerular lesions. Also patients with rapidly progressive disease may benefit Fish oil:A recent study showed that treatment with fish oil for two years retards the rate at which renal function is lost in patients with Ig A nephropathy and proteinuria [i],[ii]. The n-3 polyunsaturated fatty acids (Eicosapentaenoic acid and docosahexaenoic acid) may limit the production or action of cytokines and eicosanoids evoked by the initial immunologic renal injury. Fish oil in this study was given to patients likely to develop progression of the disease. The treatment did not affect the degree of proteinuria. The drug was administered for 2 years. Blood pressure was controlled as needed with various agents including enalapril. The results of this study should be interpreted with caution as the observation period is rather short, and the rate of development of renal failure in the placebo group was high ACE Inhibition:A recent study showed benefit in terms of decrease in proteinuria in patients with Ig A nephropathy without hypertension[iii] PlasmapheresisMay be of value in the rare patient with rapidly progressive glomerulonephritis and crescentic involvement Avoidance of food antigens e.g. gluten and alcoholmay be beneficial Non-steroidal anti-inflammatory agentsmight retard progression Aspirin and dipyridamole similar to placebo Eicosapentaenoic acid no benefit TonsillectomyMay reduce frequency of episodes of hematuria in patients with recurrent tonsillitis DanazolNo clear cut beneficial effect Phenytoincan lower IgA levels No consistent effect on the progression of disease Prophylactic penicillin, sulfonamide or broad spectrum antibioticsNo success cyclosporineTransiently decreases the proteinuria but is usually associated with further decline in GFR Cytotoxic agentsHave not been rigorously examined May be of benefit in patients with a demonstrably progressive course. May be combined with anticoagulant and antithrombotic drugs [i]van Ypersele de Strihou C, Fish oil for IgA nephropathy? [editorial; comment] N Engl J Med 1994; 331(18):1227-9 [ii]Donadio JV, et al. A controlled trial of fish oil in IgA Nephropathy. N Engl J Med 1994; 331(18):1194-9 [iii]Maschio G, Cagnoli L, Claroni F., et al. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicenter, randomized, placebo-controlled study. Nephrol Dial Transplant 1994;9:265-9 |
|
|
Copyright ©1999 This site is prepared and maintained by Editorial Staff You are visitor number For feedback or to report problems please email to Webmaster Last updated Monday, November 26, 2001 |